Angiotensinogen(1-14),Porcine CAS: 64315-16-8

CAS NO: 64315-16-8
Angiotensinogen(1-14),Porcine
Chemical Name: ANGIOTENSINOGEN
Molecular Formula: C85H123N21O20
Formula Weight: 1759.01
CAS No.: 64315-16-8
Description Review
Description

Angiotensinogen (1-14), Porcine is a peptide hormone that plays a crucial role in regulating blood pressure and fluid balance in the body. It is produced by the liver and released into the bloodstream, where it can be converted into angiotensin II, a potent vasoconstrictor that raises blood pressure.

Chemical Name Angiotensinogen (1-14), Porcine

Molecular Formula C70H102N18O17S

Formula Weight 1646.82 g/mol

CAS No. 64315-16-8

Top 10 Keywords from Google and Synonyms

  1. Renin-Angiotensin System
  2. Hypertension
  3. ACE Inhibitors
  4. Angiotensin Converting Enzyme
  5. Blood Pressure Regulation
  6. Kidney Function
  7. Cardiovascular Disease
  8. Fluid Balance
  9. Peptide Hormones
  10. Vasoconstriction

Synonyms:

  1. Angiotensinogen I
  2. AGT
  3. Angiotensin Precursor Protein
  4. Alpha-2-Globulin
  5. Serpin A8

Health Benefits of This Product Angiotensinogen (1-14), Porcine is primarily involved in the regulation of blood pressure and fluid balance in the body. By initiating the renin-angiotensin system (RAS), it can increase blood pressure by causing vasoconstriction and promoting the reabsorption of sodium and water in the kidneys.

Potential Effects The main effect of angiotensinogen (1-14), Porcine is to stimulate the production of angiotensin II, which has several potential effects on the body. These include:

  • Vasoconstriction: Angiotensin II constricts blood vessels, increasing resistance to blood flow and raising blood pressure.
  • Sodium and Water Retention: Angiotensin II promotes the reabsorption of sodium and water in the kidneys, leading to increased fluid retention and expansion of the blood volume.
  • Aldosterone Secretion: Angiotensin II stimulates the secretion of aldosterone, a hormone that promotes sodium and water retention and potassium excretion in the kidneys.
  • Sympathetic Nervous System Activation: Angiotensin II activates the sympathetic nervous system, increasing heart rate and cardiac output and further elevating blood pressure.

Product Mechanism Angiotensinogen (1-14), Porcine is a precursor protein that is cleaved by the enzyme renin to produce angiotensin I, which is then converted to angiotensin II by the action of angiotensin converting enzyme (ACE). Angiotensin II acts on various receptors in the body, including the angiotensin type 1 receptor (AT1R), to produce its effects on blood pressure and fluid balance.

Safety Angiotensinogen (1-14), Porcine is generally considered safe for use in research applications. However, as with any experimental compound, caution should be exercised when handling and administering it, and appropriate safety measures should be taken to minimize exposure.

Side Effects There are no known side effects associated with angiotensinogen (1-14), Porcine.

Dosing Information Angiotensinogen (1-14), Porcine is typically used in laboratory experiments to study the renin-angiotensin system and its effects on blood pressure and fluid balance. The appropriate dosing regimen will depend on the specific experimental design and goals of the study.

Conclusion Angiotensinogen (1-14), Porcine is a peptide hormone that plays an important role in regulating blood pressure and fluid balance in the body. By initiating the renin-angiotensin system and promoting the production of angiotensin II, it can cause vasoconstriction, promote sodium and water retention, and activate the sympathetic nervous system, all of which contribute to elevated blood pressure. While there are no known side effects associated with this product, caution should be exercised when handling and administering it in laboratory settings. Overall, angiotensinogen (1-14), Porcine is a valuable tool for studying the physiology and pharmacology of the renin-angiotensin system and its role in cardiovascular and renal function

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code